Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clerici-Sacco Group, commonly presented today through the Sacco System brand, is an Italian biotechnology group focused on microorganisms, probiotics, enzymes, starter cultures, and related ingredients for the food, nutraceutical, pharmaceutical, and agro-veterinary sectors. The group combines the historical businesses of Caglificio Clerici, Sacco, Centro Sperimentale del Latte, and related international affiliates under a holding structure. Its business is primarily B2B and centered on commercial products rather than a drug-development pipeline, with strengths in lactic acid bacteria, probiotic cultures, rennet, coagulants, enzymes, and fermentation solutions. In healthcare-adjacent markets, the company appears active mainly in nutraceutical and pharmaceutical ingredient supply rather than as a therapeutic drug developer. The organization is family-owned, Italy-based, and operates internationally through a network of regional subsidiaries and commercial entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clerici-Sacco Group.